Jonathan Kimmelman
Associate Professor
Epidemiology, Biostatistics and Occupational Health
McGill University
Canada
Biography
Biomedical Ethics Unit
Research Interest
Kimmelman's research centers on the ethical, social, and policy challenges in testing novel medical technologies in human beings ("translational clinical research"). Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. Another set of projects is pursuing alternative frameworks and understandings concerning the role and content of clinical research ethics. Kimmelman directs the Group for Studies of Translation, Ehtics, and Medicine (Stream). Click here to learn more about specific research projects.
Publications
-
Nonpublication of trial results for new neurological drugs: A systematic review. Hakala AK, Fergusson D, Kimmelman J.
-
Can cancer researchers accurately judge whether preclinical reports will reproduce? Benjamin D, Mandel DR, Kimmelman J.
-
Drug Development at the Portfolio Level Is Important for Policy, Care Decisions and Human Protections. Kimmelman J, Carlisle B, Gönen M.
